Recent SABS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 09:00:06 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/12/2024 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:30:33 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2024 09:00:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 12:00:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:30:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:30:03 PM
- SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates • GlobeNewswire Inc. • 05/20/2024 09:45:00 PM
- SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors • GlobeNewswire Inc. • 05/06/2024 11:15:00 AM
- SAB Biotherapeutics Provides SAB-142 Trial Update • GlobeNewswire Inc. • 04/16/2024 11:15:00 AM
- SAB Biotherapeutics to Present at INNODIA Annual Meeting • GlobeNewswire Inc. • 04/08/2024 11:15:00 AM
- SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/04/2024 11:15:00 AM
- SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results • GlobeNewswire Inc. • 03/29/2024 11:15:00 AM
- SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment • GlobeNewswire Inc. • 03/25/2024 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:55:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:45:19 PM
- SAB Biotherapeutics to Present at the BIO CEO & Investor Conference • GlobeNewswire Inc. • 02/23/2024 01:00:00 PM
- SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/08/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 12:53:44 PM
- SAB Biotherapeutics Announces Executive Leadership Change • GlobeNewswire Inc. • 02/02/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 09:15:19 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/26/2024 09:00:14 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM